CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Unilife Corporation is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Unilife Corporation
250 Cross Farm Lane
Phone: 717-384-3400p:717-384-3400 York, PA  17406-6200  United States

This Company's Plan of Liquidation went into effect on 12/29/2017.
This company is no longer actively traded on any major stock exchange.

Business Summary
Unilife Corporation is engaged in the designing, development and manufacturing of injectable drug delivery systems. The Company has a portfolio of product platforms, including pre-filled syringes, disposable and reusable auto-injectors, drug reconstitution delivery systems, ocular delivery systems, and other systems for the targeted delivery of injectable therapies. The majority of its products are designed for sale directly to pharmaceutical and biotechnology companies supplying them as drug-device combination products, pre-filled and ready for administration by end-users, such as health-care providers or patients. Its other products, such as reusable auto-injectors and certain systems for targeted drug delivery are designed either to be sold to pharmaceutical or biotechnology companies for use as combination products or to be sold directly to a health care provider or end user without having the device pre-filled by a pharmaceutical company.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/20166/30/2016YesYesYes--

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President, Chief Executive Officer, Director John C.Ryan 47 7/28/2016 5/8/2014
Interim Chief Financial Officer, Interim Chief Accounting Officer Dennis P.Pyers 56 6/9/2017 7/27/2010
Chief Operating Officer, Senior Vice President IanHanson 43 7/28/2016 3/14/2016
3 additional Officers and Directors records available in full report.

Business Names
Business Name
Unilife Cross Farm, LLC
Unilife Medical Solutions Limited
Unilife Medical Solutions, Inc.
UNIS
UNISQ
Unitract Syringe Pty Limited

General Information
Number of Employees: 160 (As of 6/30/2016)
Outstanding Shares: 18,147,033 (As of 2/2/2017)
Shareholders: 359
Stock Exchange: OTC
Federal Tax Id: 271049354


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023